在母亲暴露于氨酸后报告神经发育结果的时间变化:构想项目的贡献
Dimitra Gkolfi1, Yrea R J van Rijt-Weetink1, Henric Taavola-Gustafsson2
1Groningen Research Institute of Pharmacy, PharmacoTherapy, -Epidemiology and -Economics, University of Groningen, Groningen, The Netherlands.
Drug safety
|July 7, 2025
概括
在怀孕期间暴露于氨酸的儿童中,神经发育问题的报告增加了. 报告的增加与关键出版物和监管行动有关,提高人们对氨酸的安全概况的认识.
科学领域:
- 药物监督 药物监督 药物监督
- 神经发育毒理学 神经发育毒理学
- 怀孕安全 怀孕安全
背景情况:
- 在怀孕期间准确解释药物安全信号需要了解药监报告的趋势.
- 报告数量和特征的时间变化对于信号检测至关重要.
研究的目的:
- 评估母亲对氨酸暴露的不良事件报告的时间变化.
- 分析信号检测结果措施,重点关注后代的神经发育结果.
主要方法:
- 使用VigiBase数据进行的观测研究,截至2023年4月3日.
- 报告数量和事件聚类对神经发育结果的分析. 产后氨酸暴露.
- 时间趋势分析,包括出版物和监管行动的影响;集群审查的vigiGroup方法.
主要成果:
- 报告中发现,怀孕期间与氨酸暴露相关的神经发育结果的趋势越来越大.
- 随着时间的推移,与氨酸相关的不良事件报告的模式变得更加多样化.
- 报告增加与关键科学出版物和国际监管准则相关.
结论:
- 报告和意识的神经发育结果在子宫内瓦尔酸暴露后有所增加.
- 这种增长似乎与重要出版物和监管决定有关.
- 这些因素对观察到的报告趋势的确切贡献需要进一步调查.
更多相关视频
05:13Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
337
19:57The Use of Trace Eyeblink Classical Conditioning to Assess Hippocampal Dysfunction in a Rat Model of Fetal Alcohol Spectrum Disorders
Published on: August 5, 2017
8.5K
相关概念视频
01:07Teratogenicity
2.8K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.8K
01:19Pharmacovigilance
999
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
999